BioSpace News Archive

Business

Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases

Skyhawk will use its SkySTARTM platform to develop drug candidates directed to multiple targets for oncology and neurodegenerative diseases.

July 16, 2019
·
2 min read
Business

Glooko Appoints Stephen Lien as New Chief Financial Officer

Accomplished finance and operations leader brings deep experience in SaaS and healthcare technology to continue acceleration of diabetes data management leader’s growth

July 16, 2019
·
3 min read
Business

RRD International Hires Nigel Thomas, PhD as Senior Vice President, Development Operations

RRD International, a specialized product development company that provides strategic and operational support to biopharmaceutical companies and investors, announced the appointment of Nigel Thomas, PhD as senior vice president development operations.

July 16, 2019
·
2 min read
Business

Pall Corporation Chosen as Single-Source Supplier by Servier for Purpose Built End-to-End Biomanufacturing Facility in Gidy, France

Pall Corporation, a global leader in filtration, separation and purification, has been chosen by Servier, an independent international pharmaceutical company, as an exclusive technology and services provider for their Gidy, France biomanufacturing facility.

July 16, 2019
·
3 min read
Genetown

InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord

InVivo Therapeutics Holdings Corp. announced the publication of a manuscript in the peer-reviewed journal Spinal Cord describing its CONTEMPO registry study data.

July 16, 2019
·
2 min read
Drug Development

Axial Biotherapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AB-2004 for Treatment of Gastrointestinal Dysfunction and Associated Behavioral Symptoms of Autism Spectrum Disorder

AB-2004 has demonstrated the ability to repair leaky gut and improve repetitive behavior, anxiety and Autism Spectrum Disorder (ASD)-related sensorimotor gating deficits by removing key microbial metabolites.

July 16, 2019
·
2 min read
Business

Parvus Therapeutics Announces Key Executive and Board of Directors Appointments

Hugh Young Rienhoff, Jr., M.D., appointed as Chairman of the Board Charles A. Johnson, M.D., appointed to Board of Directors Alain Delcayre, Ph.D., appointed Senior Vice President of Research

July 16, 2019
·
4 min read
Business

Horizon Therapeutics plc to Release Second-Quarter 2019 Financial Results and Host Webcast on Aug. 7, 2019

Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

July 16, 2019
·
1 min read
Deals

Kindred Biosciences to Announce Second Quarter 2019 Financial Results

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time on Thursday, August 1, 2019

July 16, 2019
·
2 min read
Neovasc Provides Further Update on Reducer Program for Treatment of Refractory Angina

Pending U.S. Food and Drug Administration (“FDA”) Humanitarian Use Device (“HUD”) Classification and Approval as a HUD, Company Expects to Begin Commercializing Reducer in U.S. by Early 2020

July 16, 2019
·
11 min read